Can Macrobid (nitrofurantoin) be used to treat Group B strep (GBS) colonization in a pregnant woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Macrobid Should NOT Be Used for Group B Strep in Pregnancy

Macrobid (nitrofurantoin) is not recommended for treating Group B streptococcus (GBS) colonization in pregnant women, and antimicrobial agents should not be used before the intrapartum period to treat asymptomatic GBS colonization at all. 1

Why Treatment Before Labor Doesn't Work

The evidence clearly demonstrates that prenatal treatment of GBS colonization is ineffective:

  • Administering antimicrobial agents to pregnant women before the onset of labor or rupture of membranes is not likely to prevent neonatal GBS disease. 1

  • In studies where colonized pregnant women received oral antimicrobial drugs for 1 week during the third trimester, more than 30% were still colonized at delivery, with no substantial difference between treated and untreated groups. 1

  • Even with 12-14 days of treatment during the third trimester (including treatment of sex partners), nearly 70% of colonized women remained colonized 3 weeks later and again at delivery. 1

  • Colonization status can change between treatment and delivery, making prenatal treatment ineffective. 2

The Correct Approach: Intrapartum Prophylaxis

Intrapartum chemoprophylaxis (administration of antimicrobial agents after onset of labor or membrane rupture but before delivery) is the most likely method of preventing both early-onset disease and maternal illness resulting from GBS. 1

First-Line Agents

  • Penicillin remains the first-line agent for intrapartum antibiotic prophylaxis, with ampicillin an acceptable alternative. 1

  • All GBS isolates in multiple studies showed 100% sensitivity to penicillin G, ampicillin, and vancomycin. 3

Alternative Agents for Penicillin Allergy

  • Cefazolin is recommended for prophylaxis in women without significant penicillin allergy. 4

  • Clindamycin and vancomycin are reserved for cases of significant maternal penicillin allergy. 4

  • Pregnant women with a history of penicillin allergy should undergo skin testing, as confirmation or delabeling can provide both short- and long-term health benefits. 4

What About Nitrofurantoin Specifically?

While one study found no GBS strains resistant to nitrofurantoin 5, this does not make it appropriate for GBS prophylaxis because:

  • The CDC guidelines explicitly state that antimicrobial agents should not be used before the intrapartum period to treat asymptomatic GBS colonization. 1, 2

  • Nitrofurantoin is not listed among recommended intrapartum prophylaxis regimens in any guideline. 1, 4, 6

  • The timing of administration (intrapartum) and the specific agents used (penicillin/ampicillin) are critical to effectiveness.

Screening and Timing

  • Universal prenatal culture-based screening for vaginal and rectal GBS colonization should occur at 36 0/7 to 37 6/7 weeks' gestation (updated from the previous 35-37 weeks window). 4, 6

  • Women with GBS bacteriuria at any concentration during pregnancy require intrapartum antibiotic prophylaxis regardless of screening results, as this indicates heavy colonization. 1, 2

Critical Caveat

For non-pregnant women, GBS vaginal colonization requires no treatment whatsoever. 2, 7 Treatment is only indicated for symptomatic urinary tract infections or invasive infections, not asymptomatic colonization. 2, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Group B Streptococcus Vaginal Colonization Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Phenotypical characteristics of group B streptococcus in parturients.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2007

Guideline

Group B Streptococcus Vaginal Colonization in Non-Pregnant Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What test is indicated for a 33-year-old gravida 2 para 1 woman at 26 weeks gestation with a history of Group B Streptococcus (GBS) colonization, now presenting with minimal pedal edema and normal urinalysis results?
Is Clindamycin (clindamycin) effective for Group B Streptococcus (GBS) positive patients?
What is the most appropriate response to a 28-year-old primigravid woman at 30 weeks gestation, with a family history of neonatal group B streptococcal infection, regarding her risk of GBS infection in her baby?
What is the indication for intrapartum Group B Streptococcus (GBS) prophylaxis in a 23-year-old woman, gravida 2, para 1, at 37 weeks gestation with a history of prior term vaginal delivery complicated by intraamniotic infection and early-onset neonatal sepsis?
What is the recommended treatment for a patient with a urine culture positive for group B streptococcus (GBS) despite a negative urinalysis (UA) dipstick except for blood, while menstruating?
What is the class of drug for Trulance (plecanatide) used to treat chronic idiopathic constipation?
What is the appropriate use of Clindamycin for treating acne?
What causes dry symptoms, particularly in adults with a history of autoimmune disorders?
What is the recommended treatment for a patient with a scalp fungal infection, considering the use of antifungal shampoos?
What is the recommended treatment for a patient suspected of having Strongyloides infection, especially if they have a history of travel to tropical and subtropical regions or have a weakened immune system?
What are the contraindications for enfortumab vedotin (Enfortumab Vedotin) + pembrolizumab (Pembrolizumab) in patients with bladder cancer, particularly those with impaired renal function or a history of severe immune-mediated adverse reactions?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.